Evidence map›Paper›PMID 29847648›Full record

Observational studyInvestigative ophthalmology & visual science2018

Characterization of Visual Function, Interocular Variability and Progression Using Static Perimetry-Derived Metrics in RPGR-Associated Retinopathy.

James J L Tee, Yesa Yang, Angelos Kalitzeos, Andrew Webster, James Bainbridge, Richard G Weleber, Michel Michaelides

Registry-linked trialAbstract readObservational Study
In one paragraph

Observational study in Investigative ophthalmology & visual science, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT05537220 (NAC Attack, A Phase III, Multicenter, Randomized, Parallel, Double Masked, Placebo-Controlled Study Evaluating the Efficacy and Safety of Oral N-Acetylcysteine in Patients With Retinitis Pigmentosa), which is not on this map. Cited by 24 papers.

0numbers the graph read from it
0cells of the map it votes in
24citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT05537220 phase3active not recruitingnot on this mapstarted 2023, after this paper: background citation

NAC Attack, A Phase III, Multicenter, Randomized, Parallel, Double Masked, Placebo-Controlled Study Evaluating the Efficacy and Safety of Oral N-Acetylcysteine in Patients With Retinitis Pigmentosa

TypeinterventionalSponsorJohns Hopkins UniversityRan2023 to 2030Enrolled485ConditionsRetinitis PigmentosaArmsN-acetylcysteine, Placebo
3 · Its place in the literature

Who cites it

24 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Cold Spring Harbor perspectives in medicine · 2023
    Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Observational
  11. Analysis of imaging biomarkers and retinal nerve fiber layer thickness in RPGR-associated retinitis pigmentosa.Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie · 2021
    Article
  12. Article
  13. Article
  14. Article
  15. Long-Term Investigation of Retinal Function in Patients with Achromatopsia.Investigative ophthalmology & visual science · 2020
    Article
  16. Validation of a Vision-Guided Mobility Assessment forTranslational vision science & technology · 2020
    Article
  17. Retinal Structure in RPE65-Associated Retinal Dystrophy.Investigative ophthalmology & visual science · 2020
    Article
  18. International journal of molecular sciences · 2020
    Article
  19. Observational
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

James J L TeeUCL Institute of Ophthalmology, University College London, London, United Kingdom.
Yesa YangUCL Institute of Ophthalmology, University College London, London, United Kingdom.
Angelos KalitzeosUCL Institute of Ophthalmology, University College London, London, United Kingdom.
Andrew WebsterUCL Institute of Ophthalmology, University College London, London, United Kingdom.
James BainbridgeUCL Institute of Ophthalmology, University College London, London, United Kingdom.
Richard G WeleberCasey Eye Institute, Oregon Health & Science University, Portland, Oregon, United States.
Michel MichaelidesUCL Institute of Ophthalmology, University College London, London, United Kingdom.

Funding

Department of Health NIHR-RP-011-003Wellcome TrustWellcome Trust 099173/Z/12/Z
6 · The paper itself

Abstract

Purpose: To characterize bilateral visual function, interocular variability and progression by using static perimetry-derived volumetric and pointwise metrics in subjects with retinitis pigmentosa associated with mutations in the retinitis pigmentosa GTPase regulator (RPGR) gene. Methods: This was a prospective longitudinal observational study of 47 genetically confirmed subjects. Visual function was assessed with ETDRS and Pelli-Robson charts; and Octopus 900 static perimetry using a customized, radially oriented 185-point grid. Three-dimensional hill-of-vision topographic models were produced and interrogated with the Visual Field Modeling and Analysis software to obtain three volumetric metrics: VTotal, V30, and V5. These were analyzed together with Octopus mean sensitivity values. Interocular differences were assessed with the Bland-Altman method. Metric-specific exponential decline rates were calculated. Results: Baseline symmetry was demonstrated by relative interocular difference values of 1% for VTotal and 8% with V30. Degree of symmetry varied between subjects and was quantified with the subject percentage interocular difference (SPID). SPID was 16% for VTotal and 17% for V30. Interocular symmetry in progression was greatest when quantified by VTotal and V30, with 73% and 64% of subjects possessing interocular rate differences smaller in magnitude than respective annual progression rates. Functional decline was evident with increasing age. An overall annual exponential decline of 6% was evident with both VTotal and V30. Conclusions: In general, good interocular symmetry exists; however, there was both variation between subjects and with the use of various metrics. Our findings will guide patient selection and design of RPGR treatment trials, and provide clinicians with specific prognostic information to offer patients affected by this condition.

Indexed as

MutationAdolescentAdultChildDisease ProgressionElectroretinographyExonsEye ProteinsFollow-Up StudiesHumansMaleMiddle AgedOpen Reading FramesProspective StudiesRetinitis PigmentosaVisual AcuityEye ProteinsRPGR protein, human

Identifiers

PMID29847648
PMCPMC5947973

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.